Clinical and Genetic Relevance of Somatic Mutations in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) Patients Using Serial Sequencing

被引：0
|
作者：
Kim, Taehyung
Moon, Joon Ho
Ahn, Jae-Sook
Tyndel, Marc S.
Kim, Yeo-Kyeoung
Lee, Seung-Shin
Ahn, Seo-Yeon
Jung, Sung-Hoon
Yang, Deok-Hwan
Lee, Je-Jung
Choi, Seunghyun
Lee, Yoojin
Sohn, Sang Kyun
Min, Yoo Hong
Cheong, June-Won
Kim, Hyeoung-Joon
Zhang, Zhaolei
Kim, Dennis
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3955
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Core Binding Factor Acute Myeloid Leukemia of the Elderly Treated with Conventional Chemotherapy : A Collaborative Study of the French CBF AML Intergroup
    Prebet, Thomas
    Boissel, Nicolas
    Recher, Christian
    Thomas, Xavier
    Delaunay, Jacques
    Cahn, Jean-Yves
    Pigneux, Arnaud
    Quesnel, Bruno
    Witz, Francis
    Thepot, Sylvain
    Ugo, Valerie
    Terre, Christine
    Tavernier, Emmanuelle
    Castaigne, Sylvie
    Guilhot, Francois
    Dombret, Herve
    Vey, Norbert
    BLOOD, 2008, 112 (11) : 206 - 207
  • [22] Driver mutations in pediatric core binding factor acute myeloid leukemia
    Nasedkina, T.
    Ghukasyan, L.
    Krasnov, G.
    Baidun, L.
    Ibragimova, S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 487 - 487
  • [23] KIT Exon 8 mutations associated with core binding factor (CBF) - Acute myeloid leukemia (AML) cause hypersensitivity of KIT to its natural ligand stem cell factor
    Kohl, TM
    Schnittger, S
    Hiddemann, W
    Spiekermann, K
    BLOOD, 2004, 104 (11) : 30A - 30A
  • [24] Title: KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor
    Kohl, Tobias M.
    Schnittger, Susanne
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    ANNALS OF HEMATOLOGY, 2006, 85 : 15 - 15
  • [25] Genetic abnormalities predict outcomes in patients with core binding factor acute myeloid leukemia
    Shunjie Yu
    Sen Yang
    Lijuan Hu
    Wenbing Duan
    Ting Zhao
    Yazhen Qin
    Yazhe Wang
    Yueyun Lai
    Hongxia Shi
    Feifei Tang
    Yuqian Sun
    Jinsong Jia
    Jing Wang
    Shengye Lu
    Qiang Fu
    Hao Jiang
    Lanping Xu
    Yu Wang
    Xiaohui Zhang
    Xiaojun Huang
    Qian Jiang
    Annals of Hematology, 2025, 104 (2) : 997 - 1006
  • [26] Predictive value of molecular remissions postconsolidation chemotherapy in patients with Core Binding Factor Acute Myeloid Leukemia (CBF-AML) - a single center analysis
    Deotare, Uday
    Shaheen, Marwan
    Brandwein, Joseph M.
    Pitcher, Bethany
    Kamel-Reid, Suzanne
    Yee, Karen W. L.
    Schimmer, Aaron
    Minden, Mark D.
    Gupta, Vikas
    Schuh, Andre C.
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 810 - 813
  • [27] THREE CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIAS (CBF-AML) IN A SINGLE PATIENT
    Markova, J.
    Polak, J.
    Haskovec, C.
    Maaloufova, J.
    Markova, M.
    Soukup, P.
    Salek, C.
    Vrana, M.
    Dobrovolna, M.
    Vitek, A.
    Cetkovsky, P.
    Schwarz, J.
    HAEMATOLOGICA, 2013, 98 : 522 - 522
  • [28] Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)
    Boissel, N.
    Leroy, H.
    Brethon, B.
    Philippe, N.
    de Botton, S.
    Auvrignon, A.
    Raffoux, E.
    Leblanc, T.
    Thomas, X.
    Hermine, O.
    Quesnel, B.
    Baruchel, A.
    Leverger, G.
    Dombret, H.
    Preudhomme, C.
    LEUKEMIA, 2006, 20 (06) : 965 - 970
  • [29] Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)
    N Boissel
    H Leroy
    B Brethon
    N Philippe
    S de Botton
    A Auvrignon
    E Raffoux
    T Leblanc
    X Thomas
    O Hermine
    B Quesnel
    A Baruchel
    G Leverger
    H Dombret
    C Preudhomme
    Leukemia, 2006, 20 : 965 - 970
  • [30] Prognostic significance of WBC, age, and cytogenetics in patients with core binding factor acute myeloid leukemia (CBF-AML): A comparative study from the French AML Intergroup.
    Delaunay, J
    Leblanc, T
    Blaise, D
    Fenaux, P
    Huguet-Rigal, F
    Witz, F
    Pigneux, A
    Thomas, X
    Auvrignon, A
    Colombat, P
    Lioure, B
    Van den Akker, J
    Mugneret, F
    Bastard, C
    Dastugue, N
    Castaigne, S
    Reiffers, J
    Leverger, G
    Harousseau, JL
    Dombret, H
    BLOOD, 2002, 100 (11) : 748A - 748A
12345